Attention QP’s: Do you really have oversight of your AI systems?

BY MARTIN LUSH | GxP AI IMPLEMENTATION SPECIALIST

 

A stressed Qualified Person (QP) releasing sterile product called me recently. Her company is embedding AI across operations: predictive maintenance for autoclaves, trending of environmental monitoring data, deviation clustering. You name it.

 

Why stressed? In practice, she has little visibility of how these AI systems are designed, validated or monitored. When she questions the risks, she’s told:


“Don’t worry, you’re our Human-in-the-Loop, our system safeguard.”


She feels less like a safeguard - more like a convenient scapegoat. She is not alone.

Scientist struggling with AI integration

 

Concerned about AI risks? Learn more from Martin about AI in Pharma

 

Join his course today and leave with a fully personalised 30/60/90-day AI action plan, ready to implement from day one.
What the regulations Say - and the QP Code of Practice

 

The EU AI Act and the EudraLex Annex 22 (draft) are clear: Human oversight must be real, effective, and documented, not symbolic. The HITL (Human-in-the-loop) must understand AI, warts and all. The UK QP Code of Practice places ultimate legal responsibility on the QP for product certification. That responsibility cannot be delegated to an algorithm. Oversight means being able to challenge, override and document decisions, not rubber-stamp outputs you don’t understand.

 

If a QP is branded the “HITL" without access to the underlying data, validation evidence, or performance metrics, the company is not protecting compliance - it’s creating regulatory exposure and patient risk.

 

 

QP concerns: Lucy had many but here's her top three:

 

  • Accountability without control: She is legally accountable for release decisions but has no documented authority or tools to verify how AI outputs are generated.
  • Data integrity risk: AI-enabled equipment (e.g. autoclaves) generate outputs that feed into release. Without audit trails and validation, how can she prove compliance with ALCOA+?
  • False sense of security: Management treats “HITL” as a safety net, but without proper training, processes, and challenge mechanisms, the human becomes a fig leaf, not a safeguard. 

 

 

Five recommendations to mitigate risk? This is what we came up with:

 

1.    Define intended use & limits of AI: Each application must have a documented statement of intended use, risk assessment, and validation evidence. AI should assist - not decide - on GMP-critical outcomes.

 

2.    Mandate transparent oversight: QPs must have access to performance data, drift monitoring and audit trails. Oversight means being able to challenge and override, not just approve.

 

3.    Competency framework for HITL roles: QPs and QA staff need training in AI literacy: understanding bias, drift and validation principles. Competence must be assessed, not assumed.

 

4.    Establish governance systems: Create a cross-functional AI oversight board (QA, IT, Engineering) that reviews AI lifecycle management: validation, retraining, and performance monitoring.

 

5.    Codify “no rubber stamping” in SOPs: Procedures must explicitly require independent evidence review, second-person challenge for borderline cases, and documented rationale for decisions.

 

And Finally

If regulators walked in tomorrow and asked:

 

“Show me how your QP provides meaningful oversight of your AI-enabled systems”

 

would your company pass the test, or would your QP be left holding the liability bag? Human-in-the-Loop is not a slogan. It’s a system of controls, training, and governance. Without it, “HITL” becomes a trap: one that places QPs at unacceptable personal and professional risk.

Join Martin on his exclusive course examining the role of AI in pharma

 

AI is already being used extensively across the pharmaceutical industry, don't get left behind.

 

Learn from Martin Lush, one of the most respected voices on AI in pharma, and leave with the knowledge, tools and a personalised 30/60/90-day action plan to apply in your organisation.

 

Book early, spaces are limited. For on-site training for your team, get in touch.

 

Artificial Intelligence AI in Pharmaceuticals Training Artificial Intelligence AI in Pharmaceuticals Training
Istock 1299152059 (1)